Crystal structure of SARS-CoV-2 papain-like protease

Gao, Xiaopan, Qin, Bo, Chen, Pu, Zhu, Kaixiang, Hou, Pengjiao, Wojdyla, Justyna Aleksandra, Wang, Meitian, Cui, Sheng·2021·Acta Pharmaceutica Sinica B
DOI 10.1016/j.apsb.2020.08.014

Cited by (339)

Items 201–300 of 339

  1. Structural Basis and Inhibitor Development of SARS-CoV-2 Papain-like Protease
    Junshuai Wang, Yuancong Xu, Yishu Yang, B. X. Zhang, S Chen, Zhaoyang Li, Haojia Zhu, Huai Yu Yang, Hongtao Wang, Yubai Zhou et al. · 2026 · Molecules
  2. Entropy driven cooperativity effect in multi-site drug optimization targeting SARS-CoV-2 papain-like protease
    Lili Duan, Bolin Tang, Song Luo, Danyang Xiong, Qihang Wang, Xiaole Xu, John Z. H. Zhang · 2023 · Cellular and Molecular Life Sciences
  3. Molecular insights into natural product compounds targeting papain protease of SARS-CoV-2 through molecular dynamics simulation
    Chananya Rajchakom, Nitchakan Darai, Thitiya Boonma, Bunleu Sungthong, Ploenthip Puthongking, Somsak Nualkaew, Ployvadee Sripadung, Thanyada Rungrotmongkol, Nadtanet Nunthaboot · 2024 · Monatshefte für Chemie - Chemical Monthly
  4. Evaluating the potential of PLpro as a drug target in SARS-CoV-2: MD simulations and druggability analysis
    Noor Atatreh, Radwa E. Mahgoub, Mohammed A. Ghattas · 2025 · Results in Chemistry
  5. Identification of Potential Anti‐COVID‐19 Drug Leads from Medicinal Plants through Virtual High‐Throughput Screening
    Rohoullah Firouzi, Mitra Ashouri · 2023 · ChemistrySelect
  6. Insights into the inhibition mechanisms of MERS-CoV and SARS-CoV2 papain-like proteases by inhibitors from Crinum distichum: In vitro and in silico analysis
    Arnaud Fondjo Kouam, Florence Déclaire Mabou, Lifeng Fu, Roméol Romain Koagne, Yan Li, Brice Ayissi Owona, Elisabeth Zeuko’o Menkem, Armelle Gaelle Kwesseu Fepa, Borris Rosnay Galani Tietcheu, Fernando Reyes et al. · 2024 · South African Journal of Botany
  7. Specialized compounds of four Cameroonian spices: Isolation, characterization, and in silico evaluation as prospective SARS-CoV-2 inhibitors
    Gervais Mouthé Happi, Klev Gaïtan Sikam, Mahmoud A. A. Ibrahim, Liliane Clotilde Dzouemo, Guy-Paulin Mouthé Kemayou, Praid Likane Keuteu, Peter A. Sidhom, Shaban R. M. Sayed, Mohamed‐Elamir F. Hegazy, Jean Duplex Wansi · 2024 · Open Chemistry
  8. The role of chemical biology in the fight against SARS-CoV-2
    George M. Burslem · 2021 · Biochemical Journal
  9. Main Chemotypes of SARS-CoV-2 Reproduction Inhibitors
    Vadim Andreevich Shiryaev, Yu. N. Klimochkin · 2021 · Russian Journal of Organic Chemistry
  10. Expression of recombinant SARS-CoV-2 papain-like protease (SARS-CoV-2 PLpro) in Escherichia coli RIPL
    Maria Ulfah, Lina Mulyawati, Asep Riswoko, Is Helianti · 2022 · IOP Conference Series Earth and Environmental Science
  11. Design, synthesis and activity evaluation of dual-target inhibitors against papain-like and main proteases of porcine epidemic diarrhea virus
    Jiashu Chen, Yuxi Lin, Chenxia Gao, Zhuoya Wang, Yue Xu, Yuanyuan Zhao, Chao Xie, Chao Liu, Nan Zhou, Wenlong Shan et al. · 2025 · Journal of Advanced Research
  12. Evolution of macromolecular crystallography beamlines at the Swiss Light Source and SwissFEL
    Meitian Wang · 2025 · Journal of Synchrotron Radiation
  13. Discovery of Fragment-Based Inhibitors of SARS-CoV-2 PL Pro
    Qiangqiang Wei, Ashley J. Taylor, Mahesh A. Barmade, Kevin B. Teuscher, Somanath Chowdhury, Chideraa Apakama, Jordan Anderson-Daniels, Zhu Yongqing, D. Schultz, Tyson A. Rietz et al. · 2026 · Journal of Medicinal Chemistry
  14. Mechanistic insights into the noncovalent inhibition of SARS-CoV-2 PLpro: a multiscale computational study
    Flávio Vinícius da Silva Ribeiro, Renan Patrick da Penha Valente, Hendrik Gerhardus Kruger, Jéssica de Oliveira Araújo, José Rogério A. Silva · 2026 · Journal of Computer-Aided Molecular Design
  15. Recent Development in Small Molecules for SARS-CoV-2 and the Opportunity for Fragment-Based Drug Discovery
    Sujit Mahato · 2022 · Medicinal Chemistry
  16. Discovery of a Potential Allosteric Site in the SARS-CoV-2 Spike Protein and Targeting Allosteric Inhibitor to Stabilize the RBD Down State using a Computational Approach
    Tong Li, Zheng Yan, Wei Zhou, Qun Liu, Jinfeng Liu, Haibing Hua · 2023 · Current Computer - Aided Drug Design
  17. Identification and evaluation of antiviral activity of novel compounds targeting SARS-CoV-2 virus by enzymatic and antiviral assays, and computational analysis
    Ivana Nemčovičová, Katarína Lopušná, Iveta Štibrániová, Fabio M. Benedetti, Federico Berti, Fulvia Felluga, Sara Drioli, Mattia Vidali, Jaroslav Katrlı́k, Lucia Pažitná et al. · 2024 · Journal of Enzyme Inhibition and Medicinal Chemistry
  18. N-phenethyl-2-(1H-1,2,3-triazol-1-yl)acetamide derivatives: Synthesis, crystal structure and molecular docking studies against SARS-CoV-2
    Alberto Cedillo–Cruz, Diana Cecilia Villalobos–López, Abraham Kuri Cruz, María Isabel Aguilar, Nancy Lara‐Almazán, Diego Martı́nez-Otero, Erick Cuevas‐Yáñez · 2024 · Journal of Molecular Structure
  19. Development of acylhydrazone linked thiazoles as non-covalent dual inhibitors of SARS-CoV-2 proteases
    Vidya Jyothi Alli, Shubham Kumar Singh, Mounika Darna, V. Suresh, Swapnil Anil Sule, Aruna Jangam, Bhavita Kattula, Sarva Lakshmi Pusarapu, Jessie Thomas, Yogesh Sardana et al. · 2025 · European Journal of Medicinal Chemistry
  20. Bibliometrics Analysis and Knowledge Mapping of Fragment-Based Drug Design Research: Trends from 2015 to 2024
    Chenming He, Jirong Zhang, Runze Zhang, Liang Liu, Jielian Luo, Wen Zhang, Bangjiang Fang · 2025 · Drug Design Development and Therapy
  21. PLpro Inhibitors as a Potential Treatment for COVID-19
    Yu Han, Feng Xu · 2025 · Biomedicines
  22. Development of Masitinib Derivatives with Enhanced Mpro Ligand Efficiency and Reduced Cytotoxicity
    Cintia A. Menéndez, Adil Mohamed, Gustavo R. Pérez-Lemus, Adam M. Weiss, Benjamin W. Rawe, Guancen Liu, Alex E. Crolais, Emma Kenna, Fabian Byléhn, Walter Alvarado et al. · 2023 · Molecules
  23. SARS-CoV-2 proteins structural studies using synchrotron radiation
    M. Kosenko, G. Onkhonova, I. Susloparov, A. Ryzhikov · 2023 · Biophysical Reviews
  24. Natural Products from Marine Actinomycete Genus Salinispora Might Inhibit 3CLpro and PLpro Proteins of SARS-CoV-2: An In Silico Evidence
    Omkar Pokharkar, Grigory V. Zyryanov, Mikhail V. Tsurkan · 2023 · Microbiology Research
  25. Identification of Triazolopyrimidinyl Scaffold SARS-CoV-2 Papain-Like Protease (PLpro) Inhibitor
    Sebastjan Kralj, Marko Jukič, Miha Bahun, Luka Kranjc, Anja Kolarič, Milan Hodošček, Nataša Poklar Ulrih, Urban Bren · 2024 · Pharmaceutics
  26. Exploring natural compounds and synthetic derivatives as potential inhibitors of SARS-CoV-2 PLpro: a computational approach with enzyme inhibition and cytotoxicity assessment
    Shahkaar Aziz, Sana Khan, Alaa Karkashan, Noreen Asim, Khulud Bukhari, Rand Mohammad Almousa, Zafar Ali Shah, Khaled S. Allemailem, Wafa Abdullah I. Al‐Megrin · 2025 · Journal of Biomolecular Structure and Dynamics
  27. Inhibition of Glucosinolate Sulfatases to Combat Plutella xylostella: Development of Novel Phenylcarboxamide Derivatives for Plant-Integrated Pest Management
    Jiali Wang, Manwen Wang, Anil Ravi, Seyed–Omar Zaraei, Bilal O. Alkubaisi, Yingjie Wen, Lingda Zeng, Mohammed Ibrahim El-Gamal, Hanhong Xu · 2025 · Journal of Agricultural and Food Chemistry
  28. Benchmarking Google DeepMind’s AlphaFold 3 Performance for Protein 3D-Structure Prediction
    Yelyzaveta Duma, Alexander V. Kyrychenko · 2024 · Kharkov University Bulletin Chemical Series
  29. Potential Papain-like Protease Inhibitors Against COVID-19: A Comprehensive In Silico Based Review
    Neetu Agrawal, Shilpi Pathak, Ahsas Goyal · 2021 · Combinatorial Chemistry & High Throughput Screening
  30. Fluorine Atoms on C6H5-Corrole Affect the Interaction with Mpro and PLpro Proteases of SARS-CoV-2: Molecular Docking and 2D-QSAR Approaches
    Otávio Augusto Chaves, Cláudio E. Rodrigues-Santos, Aurea Echevarrı́a, Carolina Q. Sacramento, Natalia Fintelman Rodrigues, Jairo Ramos Temerozo, Hugo Caire Castro-Faria-Neto, Thiago Moreno L. Souza · 2022 · International Journal of Molecular Sciences
  31. Bioinformatic analysis of the whole genome sequences of SARS-CoV-2 from Indonesia
    Maria Ulfah, Is Helianti · 2021 · Iranian Journal of Microbiology
  32. In silico evaluation of S -adenosyl-L-homocysteine analogs as inhibitors of nsp14-viral cap N7 methyltranferase and PLpro of SARS-CoV-2: synthesis, molecular docking, physicochemical data, ADMET and molecular dynamics simulations studies
    Ritika Srivastava, Saroj Kumar Panda, Parth Sarthi Sen Gupta, Anvita Chaudhary, Farha Naaz, Aditya K. Yadav, Nand K. Ram, Malay Kumar Rana, Ramendra Kumar Singh, Richa Srivastava · 2023 · Journal of Biomolecular Structure and Dynamics
  33. 9-fluorenone-based synthetic sulfonamide compounds as dual inhibitors of SARS-CoV-2 Main-Protease and Papain-like Protease
    Sudesna Das, Sunnapu Prasad, Mohammed Rafi, Yasmin Begum, Sudip Dey, Akshay Joshi, Nittu Singh, Krishan Gopal Thakur, Parasuraman Jaisankar, Umesh Singh · 2025 · Molecular Diversity
  34. Design, synthesis, and binding analysis of target-specific covalent inhibitors of SARS-CoV-2 papain-like protease
    Martynas Bagdonas, Laimonas Stančaitis, Ernestas Urniežius, Audrius Zakšauskas, Aurelija Mickevičiu̅tė, Rūta Kananavičiūtė, Audronė Rukšėnaitė, Vaida Juozapaitienė, Jurgita Matulienė, Visvaldas Kairys et al. · 2025 · European Journal of Medicinal Chemistry Reports
  35. Discovery of Spiro[chromane-2,4′-piperidine] Derivatives as Irreversible Inhibitors of SARS-CoV-2 Papain-like Protease
    Qiangqiang Wei, Ashley J. Taylor, Nagaraju Miriyala, Mahesh A. Barmade, Zachary O. Gentry, Jordan Anderson-Daniels, Kevin B. Teuscher, Mackenzie M. Crow, Chideraa Apakama, Taylor M. South et al. · 2026 · Journal of Medicinal Chemistry
  36. Reconstruction of the unbinding pathways of new inhibitors of the SARS-CoV-2 papain-like protease using molecular dynamics simulation
    Pouya Rahebi, Hassan Aryapour · 2023 · Journal of Biomolecular Structure and Dynamics
  37. High-throughput screening of dual-target inhibitors for SARS-CoV-2 main protease and papain-like protease from Chebulae Fructus: in silico prediction and experimental verification
    Changjian Wang, Yipeng Cao, Qi Yang, Xinyue Wang, Zhiying Yang, Jingjing Yang, Xinru Li, Бин Ли, Yuefei Wang, Min Zhang · 2024 · Frontiers in Microbiology
  38. SARS-CoV-2 Genetic Variants Identified in Selected Regions of Ethiopia Through Whole Genome Sequencing: Insights from the Fifth Wave of COVID-19
    Getnet Hailu, Mengistu Legesse, Andargachew Mulu, Girmay Medhin, Mesfin Mengesha Tsegaye, Dawit Hailu Alemayehu, Abaysew Ayele, Atsbeha Gebreegziabxier Weldemariam, Adamu Tayachew, Adimkewu Aguine et al. · 2025 · Genes
  39. Can Medicinal Plants Help in the Treatment of the New Coronavirus? Some R & D Aspects in Slovak Republic
    Іван Саламон · 2021 · Current Perspectives on Medicinal and Aromatic Plants (CUPMAP)
  40. Fundamental aspects of the structural biology of coronaviruses
    Ignacio Lara-Hernández, Miguel Ángel Coronado-Ipiña, K. Rocha-Rosas, Mauricio Comas‐García · 2021 · Elsevier eBooks
  41. Molecular Docking Analysis of Some Bioactive Molecules of Cistus incanus Against SARS CoV-2
    Sakine Kübra ÇELİK, Elvan Üstün · 2021 · Karadeniz Fen Bilimleri Dergisi
  42. Spike Protein Potential Receptors Study: Comparative Computational Analysis Approach on SARS-CoV-2 -AC2/CD147 Complexes
    2022 · Biointerface Research in Applied Chemistry
  43. Arylamines QSAR-Based Design and Molecular Dynamics of New Phenylthiophene and Benzimidazole Derivatives with Affinity for the C111, Y268, and H73 Sites of SARS-CoV-2 PLpro Enzyme
    Gianfranco Sabadini, Marco Mellado, Cesar A. Morales-Verdejo, Jaime Mella · 2024 · Pharmaceuticals
  44. Losartan promotes cell survival following SARS-CoV-2 infection in vitro
    Reza Nejat, Ahmad Shahir Sadr, Brendan T. Freitas, Jackelyn M. Crabtree, Scott D. Pegan, Ralph A. Tripp, David J. Najafi · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  45. Mutation Landscape of SARS COV2 in Africa
    Angus A. Nassir, Clarisse Musanabaganwa, Ivan Emile Mwikarago · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  46. Special feature of COVID-19 in FMODB: Fragment molecular orbital calculations and interaction energy analysis of SARS-CoV-2 related proteins
    Kaori Fukuzawa, Koichiro Kato, Chiduru Watanabe, Yusuke Kawashima, Yuma Handa, Ami Yamamoto, Kazuki Watanabe, Tatsuya Ohyama, Kikuko Kamisaka, Daisuke Takaya et al. · 2021
  47. Integration of Computational and Experimental Techniques for the Discovery of SARS-CoV-2 PLpro Covalent Inhibitors
    Ho Ying Huang, Sharon Pinus, Xiao Cong Zhang, Guanyu Wang, Andres Mauricio Rueda, Souaibou Yaouba, Solène Huck, Mitchell J. Huot, Danielle Vlaho, Joshua Pottel et al. · 2023 · ChemRxiv
  48. Discovery of novel quinoline papain-like protease inhibitors for COVID-19 through topology constrained molecular generative model
    Yongzhi Lu, Ting Ran, Qi Yang, Guihua Zhang, Jiayi Chen, Peiqi Zhou, Wenqi Li, Minyuan Xu, Jielin Tang, Minxian Dai et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  49. Off-label and repurposed use of disulfiram beyond alcohol dependence: A systematic review of clinical and preclinical evidence
    Benkő, Beáta-Mária, De Brito Parreirinha, Neuza Sofia, Sebe, István, Zelkó, Romána · 2026 · iScience
  50. Molecular docking based comparative study of antiviral compounds on SARS-CoV-2 spike protein
    Sowmya Nagavarapu, Jitendra Kumar, Pradyut Kumar Biswal · 2024 · Natural Product Research
  51. Most accurate mutations in SARS-CoV-2 genomes identified in Uzbek patients show novel amino acid changes
    Ayubov Mirzakamol Sobitjonovich, Mukhammadjon K. Mirzakhmedov, Abdurakhmon N. Yusupov, Akmal M. Asrorov, Bakhtiyor Nosirov, Dilshod E. Usmanov, Shukhrat E. Shermatov, Khurshida Abdullaevna Ubaydullaeva, Abdusattor Abdukarimov, Zabardast Tadjiboevich Buriev et al. · 2024 · Frontiers in Medicine
  52. Evaluating phytochemicals as SARS-CoV-2 papain-like protease inhibitors: a docking, ADMET and molecular dynamics investigation
    Padmika Madushanka Wadanambi, Uthpali Mannapperuma, Nimanthi Jayathilaka · 2025 · Chemical Papers
  53. Discovery of 3-phenyl-1H-5-pyrazolylamides as PLpro inhibitors through virtual screening and structure optimization
    Chengwei Wu, Mengdie Ou, Bo Qin, Shuo Wang, Peng Li, Sheng Cui, Haihong Huang, Gang Li · 2025 · Bioorganic & Medicinal Chemistry Letters
  54. Computational Insights Into New Portulaca oleracea Alkaloids as Potential SARS‐CoV‐2 PL pro Inhibitors
    Mohammad Gasem Al-Thiabat, Maram B. Alhawarri · 2025 · Chemistry & Biodiversity
  55. Chasing allosteric inhibition of the SARS-CoV-2 PLpro via molecular dynamics simulations with flooding fragments (MDFFr)
    Jason G. Pattis, Khaled M. Elokely, Eleonora Gianti · 2025 · Journal of Computer-Aided Molecular Design
  56. Deubiquitinase inhibitors: Targeting SARS ‐ CoV ‐2 papain‐like protease with antiviral efficacy in a murine model
    Shweta Choudhary, Sanketkumar Nehul, Santhosh Kambaiah Nagaraj, Rohan Narayan, Shalja Verma, Swati Sharma, Annu Kumari, Ruchi Rani, Ankita Saha, Debabrata Sircar et al. · 2026 · FEBS Journal
  57. Crystallographic fragment screening discovers novel micromolar active inhibitors and druggable hotspots of SARS-CoV-2 PLpro
    Wei-wei Wang, Li-qing Huang, Qin Xu, Zhi-min Zhu, Minjun Li, Huan Zhou, Tian-liu Han, Shihao Zheng, Jian Li, Qi-sheng Wang et al. · 2026 · International Journal of Biological Macromolecules
  58. Integration of computational and experimental techniques for the discovery of PLpro covalent inhibitors. When large virtual screening and rational design meet
    Ho Ying Huang, Sharon Pinus, Xiaocong Zhang, Guanyu Wang, Mathilde Broquière, Richard Boulon, Andres Mauricio Rueda, Souaibou Yaouba, Solène Huck, Mitchell J. Huot et al. · 2026 · European Journal of Medicinal Chemistry
  59. Structural and dynamic characterization of papain-like protease ligand recognition using integrated computational and biochemical approaches
    Khaled S. Allemailem · 2026 · International Journal of Biological Macromolecules
  60. Perspectives for Potential Therapies for SARS-CoV-2
    Preeti S. Saxena, Kirti Singh, Poonam Jangir, Manish Nath Tripathi, Vimal Singh, Umakant Yadav, Anchal Srivastava · 2021 · International Journal of Quantitative Structure-Property Relationships
  61. Current understanding of SARS-CoV-2 papain-like protease inhibitors
    Minhyeong Choi, Sangwoo Kang, Ane Martiartu, Donghyuk Shin · 2022 · Korean Society for Structural Biology
  62. Identification of Cysteine 270 as a Novel Site for Allosteric Modulators of SARS‐CoV‐2 Papain‐Like Protease**
    Hangchen Hu, Qian Wang, Haixia Su, Qiang Shao, Wenfeng Zhao, Guofeng Chen, Minjun Li, Yechun Xu · 2022 · Angewandte Chemie
  63. In silico analysis of dietary polyphenols and their gut microbial metabolites suggest inhibition of SARS-CoV-2 infection, replication, and host inflammatory mediators
    Esther Mezhibovsky, Skyler H. Hoang, Samantha Szeto, Diana E. Roopchand · 2023 · Journal of Biomolecular Structure and Dynamics
  64. Immobilization of proteases for biomedical and industrial applications
    Marcos Paulo Cyrillo Ramos, Adrianne M. M. Brito, Iseli L. Nantes, Marcelo Yudi Icimoto · 2023 · Elsevier eBooks
  65. A novel robust inhibitor of papain-like protease (PLpro) as a COVID-19 drug
    Saeed Soleimani Asl, Mohammad Hossein Roozbahani · 2023 · Journal of Biomolecular Structure and Dynamics
  66. IN SILICO EVALUATION OF SARS-COV-2 PAPAIN-LIKE PROTEASE INHIBITORY ACTIVITY OF SOME FDA-APPROVED DRUGS
    Meryem Erol · 2023 · Ankara Universitesi Eczacilik Fakultesi Dergisi
  67. In-silico investigation of 4-nitro-N-1H-pyrazol-3-ylbenzamide towards its potential use against SARS-CoV-2: a DFT, molecular docking and molecular dynamics study
    S.V. Niranjana, B.S. Chethan, Mahesha Mahesha, K. N .Chethan Prathap, M.K. Hema, Neratur Krishnappagowda Lokanath · 2023 · Journal of Biomolecular Structure and Dynamics
  68. Deciphering the Molecular Interaction Process of Gallium Maltolate on SARS-CoV-2 Main and Papain-Like Proteases: A Theoretical Study
    Kevin Taype-Huanca, Manuel Isaías Osorio, Diego Inostroza, Luis Leyva‐Parra, Lina María Ruíz, Ana Valderrama-Negrón, Jesus Antonio Alvarado-Huayhuaz, Osvaldo Yáñez, William Tiznado · 2024 · Biophysica
  69. Exploring 7β-amino-6-nitrocholestens as COVID-19 antivirals: in silico , synthesis, evaluation, and integration of artificial intelligence (AI) in drug design: assessing the cytotoxicity and antioxidant activity of 3β-acetoxynitrocholestane
    Shahabuddin Shahabuddin, Uzma, Mohammad Azam, Mehtab Parveen, Nurul Huda Abd Kadir, Kim Min, Mahboob Alam · 2024 · RSC Medicinal Chemistry
  70. NMR screening of low molecular weight inhibitors targeting the papain‐like protease ( PLPro ) of SARS ‐ CoV ‐2
    Dennis Joshua Pyper, Sridhar Sreeramulu, Benjamin T. Lanham, Elizabeth M. Engle, David Fushman, Harald Schwalbe · 2025 · FEBS Open Bio
  71. Protocol for production and characterization of SARS-CoV-2 PLpro in Escherichia coli
    Anna De Falco, Rebecca Greene-Cramer, Ben A. Shurina, Suren Zakian, Thomas Acton, Theresa A. Ramelot, Gaetano Thomas Montelione · 2025 · STAR Protocols
  72. Molecular Multi-target Approach on COVID-19 for Designing Novel Chemicals
    Pawan Kumar, Indira Ghosh · 2021 · Methods in pharmacology and toxicology
  73. Microbial based natural compounds as potential inhibitors for SARS-CoV-2 Papain-like protease (PLpro): a molecular docking and dynamic simulation study
    S. Rahul, Angana Sarkar · 2021 · Journal of Biomolecular Structure and Dynamics
  74. Identification of a Papain-Like Protease Inhibitor with Potential for Repurposing in Combination with an Mpro Protease Inhibitor for Treatment of SARS-CoV-2
    Jesus J. Campagna, Barbara M. Jagodzinska, Pablo Alvarez, Constance Yeun, Patricia Spilman, Kathryn M. Enquist, Whitaker Cohn, Pavla Fajtová, Anthony J. O’Donoghue, Vaithilingaraja Arumugaswami et al. · 2022 · Archives of Clinical and Biomedical Research
  75. Identification of C270 as a novel site for allosteric modulators of SARS-CoV-2 papain-like protease
    Hangchen Hu, Qian Wang, Haixia Su, Qiang Shao, Wenfeng Zhao, Guofeng Chen, Minjun Li, Yechun Xu · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  76. Simulations of conformational changes and enzyme-substrate interactions in protein drug targets
    Laura A. Tesmer · 2022
  77. Mechanistic Insights into Targeting SARS-CoV-2 Papain-Like Protease in the Evolution and Management of COVID-19: A Comprehensive Review
    Nonjabulo Ntombikhona Magwaza, Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, Rene Bernadette Khan, Hezekiel Mathambo Kumalo · 2023 · Preprints.org
  78. Computational Mechanistic Insights into Reversible and Irreversible Covalent Inhibitors Targeting SARS-CoV-2 Mpro
    Mojgan Asadi, Ashim Nandi, Arieh Warshel · 2024 · ChemRxiv
  79. Covalent DNA-Encoded Library Workflow Drives Discovery of SARS-CoV-2 Non-structural Proteins Inhibitors
    Xiaojie Lu, Hangchen Hu, Lianghe Mei, Xudong Wang, Liwei Xiong, Ying Zhu, Sixiu Liu, Wenfeng Zhao, Mengnisa Seydimemet, Linjie Li et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  80. Virtual Screening of Phyto Chemicals Against SARS-CoV-2 Targets
    Shahanas Naisam, V. S. Vidhya, Suvanish Kumar, Nidhin Sreekumar · 2021 · International Journal of Quantitative Structure-Property Relationships
  81. In Silico Exploration of Efficacious Inhibitors for SARS-CoV-2’s Papain-like Protease
    Tien Huynh, Wendy D. Cornell, Binquan Luan · 2020 · ChemRxiv
  82. In Silico Determination of Potential Vaccine and Drug Targets for SARS-CoV-2
    Stephen Tavasi Ndombi · 2022 · International Journal of Innovative Research and Development
  83. Busca por candidatos a fármacos contra viroses epidêmicas e pandêmicas, como alvo a RNA-polimerase dependente de RNA (nsP4) do Alfavirus Chikungunya e a papain-like protease (PL-pro) do Betacoronavirus SARS-CoV-2
    M. B. G. dos FREIRE · 2022
  84. A sigmoid curve analysis method for pharmacological experimental results
    Qing‐Xia Niu, Chengyan Zhao · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  85. MANIFESTAÇÕES CLÍNICAS PREVALENTES NA SÍNDROME INFLAMATÓRIA MULTISSISTÊMICA PEDIÁTRICA PÓS COVID-19: UMA REVISÃO DE LITERATURA
    Tamara Ribeiro de Oliveira, Carolina Da Lozzo Mello, Ana Rhara Bergemann Souza Oliva Lima, Bruna Maria Rodrigues Yochida · 2022 · Editora Conhecimento Livre eBooks
  86. ASSISTÊNCIA A PESSOAS PORTADORAS DE LESÃO POR PRESSÃO
    Amanda Borba Barbosa, Lorena Daher Carneiro Oliva, Janaina Nascimento Lassala, Patricia Bispo da Silva, Georgia Neves da Silva, Roseli Oliveira Almeida, Ana Paula Fernandes de Carvalho, Andréia de Jesus Soares, Rosangela Ribeiro de Souza, Ana Carla Barbosa de Oliveira · 2022 · Editora Conhecimento Livre eBooks
  87. Relato de Caso Leishmaniose Tegumentar Americana ocorrido no município de Itaperuna, RJ, com revisão de literatura
    Bruna Fontes Passalini Gonçalves, João Marcos Moreira de Oliveira, Alexandre Harfouche Filipo Fernandes · 2022 · Editora Conhecimento Livre eBooks
  88. Doença articular degenerativa, artrose ou osteoartrose: relato de caso
    João Victor Pinto de Arruda Guimarães, Lucas da Cruz Farias, Amanda Tadiane Mocelin, Daniel Mocelin Neto, Luana Clementino Martiniano · 2022 · Editora Conhecimento Livre eBooks
  89. Repercussões do uso abusivo de anabolizantes na função sexual masculina.
    Alexandre Eustáquio de Almeida Rezende Filho, Victória Carneiro Maciel, Lucca Piacesi Muniz de Melo, Matheus Serwy Fiuza de Moraes, Gabriel Gomes Knust de Sousa, João Victor da Costa, João Victor de Assis Crispim, Vinícius Duarte Silva, Ana Luiza Café Lopes, Maria Vitória Graça Couto de Campos Amaral · 2022 · Editora Conhecimento Livre eBooks
  90. USO INADEQUADO DE TERAPIA HORMONAL POR MULHERES NO CLIMATÉRIO
    Nathalia Alfaix Martins Palheiro Vicente, FELIPE RODRIGUES BRAZ, LAURO BARBOSA NETO, NILTON SANTOS QUIRINO, TIAGO CANDIDO DE SÁ · 2022 · Editora Conhecimento Livre eBooks
  91. Desafios encontrados na minimização dos erros de medicação em ambientes hospitalares
    Mirelly Santos França, Gabriel de Oliveira Medeiros, Evelin Isabele Rosa Mendes · 2022 · Editora Conhecimento Livre eBooks
  92. PANORAMA CIENTÍFICO DA CATARATA CONGÊNITA: UMA REVISÃO DE LITERATURA
    Beatriz Nunes Ferraz de Abreu Zech Sylvestre, Tatiana Pinheiro Dantas, João Crispim Moraes Lima Ribeiro, Juliana de Lucena Martins Ferreira · 2022 · Editora Conhecimento Livre eBooks
  93. PRINCIPAIS FATORES ENVOLVIDOS NA INCIDÊNCIA DO TRANSTORNO DO ESPECTRO AUTISTA: UMA REVISÃO DE LITERATURA INTEGRATIVA
    Dhyeillen Ayllen Weber, Camila Vasquez Barros, Maria Fernanda Boehm Piovezan, Mariana Santana dos Santos Giolo, Paula Helena de Almeida Gattass Bumlai · 2022 · Editora Conhecimento Livre eBooks
  94. PERFIL DA RESPOSTA IMUNOLÓGICA NA COVID-19
    Renata Dellalibera-Joviliano, Carlos Eduardo Kakunaka, Yuri Felix Pedra, Edileine Dellalibera · 2022 · Editora Conhecimento Livre eBooks
  95. EXISTE INFLUÊNCIA DA TORÇÃO TESTICULAR UNILATERAL NA FERTILIDADE MASCULINA? - UMA REVISÃO DA LITERATURA
    Natalia Velasco de Azevedo, Marina Grzybowski Paranhos · 2022 · Editora Conhecimento Livre eBooks
  96. A PARTICIPAÇÃO DO MECANISMO INFLAMATÓRIO DO ÓXIDO NÍTRICO NAS LESÕES DO TECIDO CARDÍACO
    Bruno Lepera Estabile, Victor Antonio Costa Faria, Renata Dellalibera-Joviliano · 2022 · Editora Conhecimento Livre eBooks
  97. SARS-CoV-2 papain-like protease inhibits IL-1β maturation and pyroptosis through disruption of ASC oligomerization and deubiquitination of ASC
    Huan Meng, Jianglin Zhou, Xiaojuan Chen, Mingyu Wang, Mei Zheng, Yunhui Li, Ying Han, Jin Chen, Jinyu Han, Jing Liang et al. · 2023
  98. Inhibitory potentials of ivermectin, nafamostat, and camostat on spike protein and some nonstructural proteins of SARS-CoV-2: Virtual screening approach
    Haruna Isiyaku Umar, Ijeoma Akunna Duru, Uchechi Emmanuela Enenebeaku, Lynda Chioma Ngozi Olehi, Christian Ebere Enyoh, Chidi Edbert Duru · 2022 · Jurnal Teknologi Laboratorium
  99. The Search for Potential SARS-CoV-2 Inhibitors Using the In Silico Research
    Мarharyta Suleiman, Andrii I. Fedosov, Ranjan K. Mohapatra, Irina A. Sych, Lina A. Grinevich, Natalia Kobzar, Vitaliy Yaremenko, Lina O. Perekhoda · 2023 · Journal of organic and pharmaceutical chemistry
  100. De Novo Drug Design of Potential Inhibitors of SARS-CoV-2 Papain-like Protease
    Edgar Clyde R. Lopez · 2023 · International Electronic Conference on Biomedicines (IECBM)